1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.
about
The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyVitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.Targeting p53 by small molecules in hematological malignancies.Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3.Pharmacologic activation of p53 by small-molecule MDM2 antagonistsResults of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemiaDifferentiation therapy of acute myeloid leukemia.Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia.Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia.High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome.Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.
P2860
Q26799596-0A018DFE-713D-4489-9301-598DCCF757E1Q33709226-6506E6F0-B6FB-46A7-8F47-4FFD2357683EQ34581838-F80E3C6E-40AF-4161-9790-18DDFF9547EBQ34636996-B9947D77-2533-4AB6-A824-6ED59C845EB0Q36043175-C2BE8400-6208-450D-9DC3-F56F4CB567F9Q36731603-607B7B37-6789-4E70-9787-360268582DD2Q36734163-2E646A21-15FE-4AA6-96CA-D0C74E7D36A6Q37407488-5578C769-6736-4DE0-864F-E32A0FE9EDE2Q38161360-FF8B10AF-0A62-4700-B818-4BDE407C3657Q38740563-6B4DF4FC-EE43-4801-8EE8-ED6595418586Q39037456-989CD20B-6FFC-461F-B9BE-B0FA1B643C73Q42285092-0D63C3D7-930B-44DE-BEEC-FFBBA5295581Q46958342-B4395716-BE53-421E-9673-F81AA3CDF105
P2860
1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
1,25-dihydroxyvitamin D3 enhan ...... ells expressing wild-type p53.
@ast
1,25-dihydroxyvitamin D3 enhan ...... ells expressing wild-type p53.
@en
type
label
1,25-dihydroxyvitamin D3 enhan ...... ells expressing wild-type p53.
@ast
1,25-dihydroxyvitamin D3 enhan ...... ells expressing wild-type p53.
@en
prefLabel
1,25-dihydroxyvitamin D3 enhan ...... ells expressing wild-type p53.
@ast
1,25-dihydroxyvitamin D3 enhan ...... ells expressing wild-type p53.
@en
P2093
P2860
P1476
1,25-dihydroxyvitamin D3 enhan ...... ells expressing wild-type p53.
@en
P2093
George P Studzinski
Lyubomir T Vassilev
Thelma Thompson
P2860
P304
P356
10.1158/1535-7163.MCT-09-1036
P577
2010-04-20T00:00:00Z